… cytokine release in response to viral infection, a condition known as cytokine release syndrome
(CRS) or cytokine … to ARDS and MOF in COVID-19, thus endorsing the hypothesis that …

… We describe a case of CRS caused by severe COVID-19 infection with a favourable … -6
(IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (…

… cells of COVID-19 patients once treated with Gal-9 in vitro. Our results propose Gal-9 as an
important contributing factor in cytokine release syndrome; … activation in COVID-19 patients. …

… after initiating IL-6 antagonists. In summary, IL-6 pathway inhibition in severe COVID-19 may
… These agents may carry benefits in COVID-19 infection as well as safety risks such as bone …

… In conclusion, the cytokine release syndrome occurs in a majority of patients with severe
COVID-19, which is also an … IL-6 and JAK are the key molecules involved in the cytokine …

… by severe acute respiratory syndrome coronavirus 2 (SARS-… In the clinic, most patients
with COVID-19 show none or mild … -induced cytokine release syndrome (the so-called “cytokine …

… This drug has been used successfully in numerous autoimmune and auto-inflammatory
conditions, including cytokine release syndrome (CRS) secondary to CAR-T cell therapy and …

… understanding of the cytokine storm in severe COVID-19. Therefore… strategies for the cytokine
storm in severe COVID-19. … 1, and cytokine secretion patterns based on COVID-19 severity …

… In a cohort of 299 COVID-19 patients, a cHIS score ≥2 was associated with 92… a cytokine
“storm” in COVID-19. Although it is unquestionable that the values of proinflammatory cytokines …

… release syndrome (CAR T-cell CRS) became apparent [3–5]. The … cytokines, in severe
COVID-19, peripheral blood mononuclear cells exhibit sustained TNF-α and IL-6 production with …